Brochure
11 Oct 2021

Kolinpharma portfolio

PDF 339 kB

We develop and market premium patented nutraceuticals and medical devices. We are specialized in uro-gynecology, orthopedics and immune health. Right now we are looking for distributors.

Content provided by our supplier

Kolinpharma

  • Country/Region:
    Italy
  • On CPHI since:
    2020
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Distributor/Import Export
Primary activities
Nutraceuticals

Other Content from Kolinpharma (1)

  • News KOLINPHARMA®: 3 new patents in Europe and in USA, now rise to 44 the total of patents.

    The Enterprise has achieved 2 new EU patents with validity in Germany, France, and Italy, and 1 USA patent to confirm the efficacy and validity of the activity of R&D.

    Milesax, which has achieved the concession of European patent and validity in Germany, France, and Italy, it is a food supplement formulated for well-being of the muscle.

    Ivuxur, which has achieved the concession of European patent and validity in Germany, France, and Italy, it is a food supplement formulated for well-being of the urinary tract.

    Almetax, which has achieved the concession of USA patent, it is a food supplement formulated thinking of the well-being of women in the period of menopause.

    Rita Paola Petrelli, President of Kolinpharma, has commented: “We are proud to communicate that we have achieved new international patents, which allowed us to give major value of our products and the productive operation of the internal department of R&D.
    ...